Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Leonhardt

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
L'Encephale|July 1, 1989
[Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover]R Bernasconi, A F Steulet, D Aryee, et al.
Journal of Neural Transmission. Supplementum|January 1, 1992
Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptorsR Bernasconi, J Lauber, C Marescaux, et al.
European Journal of Pharmacology|November 20, 1990
Effects of selective dopamine D1 and D2 receptor agonists on the rate of GABA synthesis in mouse brainA F Steulet, R Bernasconi, T Leonhardt, et al.
American Journal of Obstetrics and Gynecology|May 1, 1988
Elevated 7B2 levels during normal human pregnancyU T Leonhardt, J C Stevenson, M A Ghatei, et al.
Neuropharmacology|February 1, 1997
A novel splice variant of a metabotropic glutamate receptor, human mGluR7bP J Flor, H Van Der Putten, D Rüegg, et al.
Neuropharmacology|September 7, 2000
Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotectiveV Bruno, I Ksiazek, G Battaglia, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal deathV Bruno, G Battaglia, I Ksiazek, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivoF Gasparini, V Bruno, G Battaglia, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
L'Encephale|July 1, 1989
[Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover]R Bernasconi, A F Steulet, D Aryee, et al.
Journal of Neural Transmission. Supplementum|January 1, 1992
Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptorsR Bernasconi, J Lauber, C Marescaux, et al.
European Journal of Pharmacology|November 20, 1990
Effects of selective dopamine D1 and D2 receptor agonists on the rate of GABA synthesis in mouse brainA F Steulet, R Bernasconi, T Leonhardt, et al.
American Journal of Obstetrics and Gynecology|May 1, 1988
Elevated 7B2 levels during normal human pregnancyU T Leonhardt, J C Stevenson, M A Ghatei, et al.
Neuropharmacology|February 1, 1997
A novel splice variant of a metabotropic glutamate receptor, human mGluR7bP J Flor, H Van Der Putten, D Rüegg, et al.
Neuropharmacology|September 7, 2000
Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotectiveV Bruno, I Ksiazek, G Battaglia, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal deathV Bruno, G Battaglia, I Ksiazek, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivoF Gasparini, V Bruno, G Battaglia, et al.
Pageof 2